Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized evaluation of trachoma treatment and relapse in children in an urban slum in Enugu State, Nigeria
PACTR202506650521073Phase 3Unknown
- Sponsor
- Royal Society of Tropical Medicine and Hygiene
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of azithromycin in trachoma and Chlamydia trachomatis infection (2 arms), sponsored by Royal Society of Tropical Medicine and Hygiene. Primary endpoint: Time to relapse of Chlamydia trachomatis infection after initial antibiotic treatment. Status: unknown.
02
Drugs
azithromycin
03
Conditions
trachomaChlamydia trachomatis infection
Beyond the preview
Go deeper on PACTR202506650521073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506650521073.